Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Nov;54(2):387–396.

Autoantibodies in three populations of Burkitt's lymphoma patients.

E Vainio, G M Lenoir, R M Franklin
PMCID: PMC1535875  PMID: 6317239

Abstract

Autoantibodies against actin, intermediate filaments, single stranded DNA and histones were found in the sera of Burkitt's lymphoma (BL) patients and normal controls from tropical Africa, where there is a high incidence of BL. Both groups had significantly higher levels of these autoantibodies than Caucasian normal controls or patients with other malignant diseases, as well as Epstein-Barr (EB) virus positive and EB virus negative BL patients from regions of North Africa and France where the incidence is lower than in tropical Africa. No linear correlation could be seen between autoantibody levels and anti-EB virus/VCA or EBNA titres in patients and controls from tropical Africa. The results suggest that a factor independent of EB virus causes an immunological imbalance and autoantibody production in the population from tropical Africa. This factor may be one of several which results in a high incidence of BL in tropical Africa.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adu D., Williams D. G., Quakyi I. A., Voller A., Anim-Addo Y., Bruce-Tagoe A. A., Johnson G. D., Holborow E. J. Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol. 1982 Aug;49(2):310–316. [PMC free article] [PubMed] [Google Scholar]
  2. BURKITT D. A children's cancer dependent on climatic factors. Nature. 1962 Apr 21;194:232–234. doi: 10.1038/194232a0. [DOI] [PubMed] [Google Scholar]
  3. Brack C., Bickle T. A., Yuan R. The relation of single-stranded regions in bacteriophage PM2 supercoiled DNA to the early melting sequences. J Mol Biol. 1975 Aug 25;96(4):693–702. doi: 10.1016/0022-2836(75)90146-1. [DOI] [PubMed] [Google Scholar]
  4. Bretherton L., Toh B. H. IgM autoantibody to intermediate filaments in infectious mononucleosis. J Clin Lab Immunol. 1981 Jan;5(1):7–10. [PubMed] [Google Scholar]
  5. Burkitt D. P. Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus. J Natl Cancer Inst. 1969 Jan;42(1):19–28. [PubMed] [Google Scholar]
  6. Burkitt D. Burkitt's lymphoma outside the known endemic areas of Africa and New Guinea. Int J Cancer. 1967 Nov 15;2(6):562–565. doi: 10.1002/ijc.2910020603. [DOI] [PubMed] [Google Scholar]
  7. Dighiero G., Guilbert B., Avrameas S. Naturally occurring antibodies against nine common antigens in humans sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies. J Immunol. 1982 Jun;128(6):2788–2792. [PubMed] [Google Scholar]
  8. Geisler N., Weber K. Purification of smooth-muscle desmin and a protein-chemical comparison of desmins from chicken gizzard and hog stomach. Eur J Biochem. 1980 Oct;111(2):425–433. doi: 10.1111/j.1432-1033.1980.tb04957.x. [DOI] [PubMed] [Google Scholar]
  9. Geser A., de Thé G., Lenoir G., Day N. E., Williams E. H. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer. 1982 Apr 15;29(4):397–400. doi: 10.1002/ijc.2910290406. [DOI] [PubMed] [Google Scholar]
  10. Gripenberg M., Linder E., Kurki P., Engvall E. A solid phase enzyme-linked immunosurbent assay (ELISA) for the demonstration of antibodies against denatured, single-stranded DNA in patient sera. Scand J Immunol. 1978;7(2):151–157. doi: 10.1111/j.1365-3083.1978.tb00438.x. [DOI] [PubMed] [Google Scholar]
  11. Guilbert B., Dighiero G., Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol. 1982 Jun;128(6):2779–2787. [PubMed] [Google Scholar]
  12. Halbert S. P., Anken M. Auto-antibodies in infectious mononucleosis, as determined by ELISA. Int Arch Allergy Appl Immunol. 1982;69(3):257–261. doi: 10.1159/000233180. [DOI] [PubMed] [Google Scholar]
  13. Haynes B. F., Schooley R. T., Payling-Wright C. R., Grouse J. E., Dolin R., Fauci A. S. Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol. 1979 Nov;123(5):2095–2101. [PubMed] [Google Scholar]
  14. Henle G., Henle W., Clifford P., Diehl V., Kafuko G. W., Kirya B. G., Klein G., Morrow R. H., Munube G. M., Pike P. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst. 1969 Nov;43(5):1147–1157. [PubMed] [Google Scholar]
  15. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hillyer G. V. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of hamsters and man infected with schistosomes. Proc Soc Exp Biol Med. 1971 Mar;136(3):880–883. doi: 10.3181/00379727-136-35386. [DOI] [PubMed] [Google Scholar]
  17. Lamelin J. P., Williams E. H., Souissi T., De-Thé G., Gabbiani G. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma. Clin Exp Immunol. 1977 Apr;28(1):157–162. [PMC free article] [PubMed] [Google Scholar]
  18. Lenoir G. M., Preud'homme J. L., Bernheim A., Berger R. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature. 1982 Jul 29;298(5873):474–476. doi: 10.1038/298474a0. [DOI] [PubMed] [Google Scholar]
  19. Lindsley H. B., Kysela S., Steinberg A. D. Nucleic acid antibodies in African trypanosomiasis: studies in Rhesus monkeys and man. J Immunol. 1974 Dec;113(6):1921–1927. [PubMed] [Google Scholar]
  20. MacDermott R. P., Wells R. A., Zolyomi S., Pavanand K., Phisphumvidhi P., Permpanich B., Gilbreath M. Examination of peripheral blood mononuclear cells and sera from Thai adults naturally infected with malaria in assays of blastogenic responsiveness to mitogenic lectins and allogeneic cell surface antigens. Infect Immun. 1980 Dec;30(3):781–785. doi: 10.1128/iai.30.3.781-785.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Matus A., Pehling G., Ackermann M., Maeder J. Brain postsynaptic densities: the relationship to glial and neuronal filaments. J Cell Biol. 1980 Nov;87(2 Pt 1):346–359. doi: 10.1083/jcb.87.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. O'Connor G. T. Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor. Am J Med. 1970 Mar;48(3):279–285. doi: 10.1016/0002-9343(70)90057-4. [DOI] [PubMed] [Google Scholar]
  23. Pedersen J. S., Toh B. H., Locarnini S. A., Gust I. D., Shyamala G. N. Autoantibody to intermediate filaments in viral hepatitis. Clin Immunol Immunopathol. 1981 Nov;21(2):154–161. doi: 10.1016/0090-1229(81)90204-x. [DOI] [PubMed] [Google Scholar]
  24. Pedersen J. S., Toh B. H., Mackay I. R., Tait B. D., Gust I. D., Kastelan A., Hadzic N. Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol. 1982 Jun;48(3):527–532. [PMC free article] [PubMed] [Google Scholar]
  25. Philip T., Lenoir G. M., Bryon P. A., Gerard-Marchant R., Souillet G., Philippe N., Freycon F., Brunat-Mentigny M. Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br J Cancer. 1982 May;45(5):670–678. doi: 10.1038/bjc.1982.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Preud'homme J. L., Brouet J. C., Danon F., Flandrin G., Schaison G. Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin. J Natl Cancer Inst. 1981 Feb;66(2):261–264. [PubMed] [Google Scholar]
  27. Rosén A., Gergely P., Jondal M., Klein G., Britton S. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature. 1977 May 5;267(5606):52–54. doi: 10.1038/267052a0. [DOI] [PubMed] [Google Scholar]
  28. Steinert P. M., Idler W. W., Zimmerman S. B. Self-assembly of bovine epidermal keratin filaments in vitro. J Mol Biol. 1976 Dec 15;108(3):547–567. doi: 10.1016/s0022-2836(76)80136-2. [DOI] [PubMed] [Google Scholar]
  29. Sutton R. N., Emond R. T., Thomas D. B., Doniach D. The occurrence of autoantibodies in infectious mononucleosis. Clin Exp Immunol. 1974 Jul;17(3):427–436. [PMC free article] [PubMed] [Google Scholar]
  30. Svedmyr E., Jondal M. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1622–1626. doi: 10.1073/pnas.72.4.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Toh B. H., Yildiz A., Sotelo J., Osung O., Holborow E. J., Kanakoudi F., Small J. V. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol. 1979 Jul;37(1):76–82. [PMC free article] [PubMed] [Google Scholar]
  32. Yoshida T. O., Yasuda-Yasaki Y., Utsumi K. R. Auto-antibodies in the sera of patients with nasopharyngeal carcinoma. IARC Sci Publ. 1975;(11 Pt 2):259–273. [PubMed] [Google Scholar]
  33. Zech L., Haglund U., Nilsson K., Klein G. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer. 1976 Jan 15;17(1):47–56. doi: 10.1002/ijc.2910170108. [DOI] [PubMed] [Google Scholar]
  34. de-The G. Is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus? Lancet. 1977 Feb 12;1(8007):335–338. doi: 10.1016/s0140-6736(77)91137-0. [DOI] [PubMed] [Google Scholar]
  35. de-Thé G., Geser A., Day N. E., Tukei P. M., Williams E. H., Beri D. P., Smith P. G., Dean A. G., Bronkamm G. W., Feorino P. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978 Aug 24;274(5673):756–761. doi: 10.1038/274756a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES